Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MITCHELL S CAIRO

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1669446399
CMS profile
165923
Location
HAWTHORNE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$288,369.35

290 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
SERVIER PHARMACEUTICALS LLC $137,919.08 202
JAZZ PHARMACEUTICALS INC. $39,671.24 35
GENZYME CORPORATION $32,386.60 16
Kite Pharma, Inc. $21,000.00 3
Amgen Inc. $13,070.90 15
Sobi, Inc $11,929.87 13
Celularity Inc. $10,069.06 2
E.R. Squibb & Sons, L.L.C. $8,400.00 1
PFIZER INC. $7,060.00 1
AstraZeneca UK Limited $6,850.00 1
ABBVIE INC. $12.60 1

Page 3 of 6; records 101–150 of 290 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MITCHELL S CAIRO

NPI 1669446399 · CMS profile ID 165923

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Hematology-Oncology

HAWTHORNE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 290 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669446399?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MITCHELL S CAIRO, NPI 1669446399, CMS profile ID 165923. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 290 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669446399?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MITCHELL S CAIRO, NPI 1669446399, CMS profile ID 165923. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 290 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669446399?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MITCHELL S CAIRO, NPI 1669446399, CMS profile ID 165923, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 290 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1669446399?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

290 matching records · $288,369.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 290 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 290.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Servier Pharmaceuticals LLC $2,380.0005/18/2022 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147297 CMS
JAZZ PHARMACEUTICALS INC. $25.5105/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398679 CMS
JAZZ PHARMACEUTICALS INC. $228.6005/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398681 CMS
JAZZ PHARMACEUTICALS INC. $261.0605/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398683 CMS
JAZZ PHARMACEUTICALS INC. $58.5005/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398685 CMS
JAZZ PHARMACEUTICALS INC. $20.0005/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398687 CMS
SERVIER PHARMACEUTICALS LLC $93.5305/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205705 CMS
SERVIER PHARMACEUTICALS LLC $353.2805/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205707 CMS
SERVIER PHARMACEUTICALS LLC $4,675.0005/12/2022 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205711 CMS
SERVIER PHARMACEUTICALS LLC $525.2005/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205721 CMS
SERVIER PHARMACEUTICALS LLC $93.5305/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205833 CMS
SERVIER PHARMACEUTICALS LLC $353.2805/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205861 CMS
SERVIER PHARMACEUTICALS LLC $525.2005/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205865 CMS
SERVIER PHARMACEUTICALS LLC $4,675.0005/12/2022 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205881 CMS
Servier Pharmaceuticals LLC $93.5305/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147099 CMS
Servier Pharmaceuticals LLC $353.2805/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147101 CMS
Servier Pharmaceuticals LLC $4,675.0005/12/2022 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147105 CMS
Servier Pharmaceuticals LLC $525.2005/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147115 CMS
Servier Pharmaceuticals LLC $93.5305/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147227 CMS
Servier Pharmaceuticals LLC $353.2805/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147255 CMS
Servier Pharmaceuticals LLC $525.2005/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147259 CMS
Servier Pharmaceuticals LLC $4,675.0005/12/2022 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147275 CMS
JAZZ PHARMACEUTICALS INC. $5,760.0005/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398699 CMS
JAZZ PHARMACEUTICALS INC. $320.0005/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951398921 CMS
SERVIER PHARMACEUTICALS LLC $92.9805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205775 CMS
SERVIER PHARMACEUTICALS LLC $92.9805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205799 CMS
Servier Pharmaceuticals LLC $92.9805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147169 CMS
Servier Pharmaceuticals LLC $92.9805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965147193 CMS
JAZZ PHARMACEUTICALS INC. $151.7305/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951358459 CMS
JAZZ PHARMACEUTICALS INC. $14.9805/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951358463 CMS
GENZYME CORPORATION $2,874.0004/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938810605 CMS
Sobi, Inc $2,200.0004/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940376601 CMS
Sobi, Inc $2,043.1004/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940376603 CMS
Sobi, Inc $124.2904/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940376611 CMS
Sobi, Inc $406.1004/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940376635 CMS
AstraZeneca UK Limited $6,850.0004/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915145667 CMS
SERVIER PHARMACEUTICALS LLC $48.0004/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205731 CMS
SERVIER PHARMACEUTICALS LLC $58.5004/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205735 CMS
SERVIER PHARMACEUTICALS LLC $47.9704/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205741 CMS
SERVIER PHARMACEUTICALS LLC $54.3104/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205745 CMS
SERVIER PHARMACEUTICALS LLC $54.3104/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205747 CMS
SERVIER PHARMACEUTICALS LLC $132.0004/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205751 CMS
SERVIER PHARMACEUTICALS LLC $58.5004/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205755 CMS
SERVIER PHARMACEUTICALS LLC $13.9104/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205759 CMS
SERVIER PHARMACEUTICALS LLC $46.5404/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205761 CMS
SERVIER PHARMACEUTICALS LLC $11.9204/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205763 CMS
SERVIER PHARMACEUTICALS LLC $49.3204/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205765 CMS
SERVIER PHARMACEUTICALS LLC $49.3204/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205787 CMS
SERVIER PHARMACEUTICALS LLC $47.9704/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205793 CMS
SERVIER PHARMACEUTICALS LLC $46.5404/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964205807 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $90,338.41 66
PY2020 $156,210.07 87
PY2021 $137,840.27 78
PY2022 $288,369.35 290
PY2023 $170,349.04 108
PY2024 $116,759.76 96
PY2025 $147,997.18 110

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $13,500.00 1
PY2025 Principal investigator $464,771.85 18
PY2024 Recipient $10,825.00 3
PY2024 Principal investigator $432,005.04 18
PY2023 Principal investigator $488,137.97 33
PY2022 Recipient $1,027.96 7
PY2022 Principal investigator $1,701,976.90 16
PY2021 Principal investigator $1,304,225.76 14
PY2020 Principal investigator $533,281.90 14
PY2019 Principal investigator $3,751,222.42 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,012.50 11/26/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202525458
Principal investigator 1 ABBVIE INC. $168.75 10/16/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202517165
Principal investigator 1 Servier Pharmaceuticals LLC $116,144.52 09/25/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
Not supplied No dispute reported 06/30/2026 1235972419
Principal investigator 1 Spectrum Pharmaceuticals Inc. $40,468.47 09/17/2025 Non-covered Recipient Entity
NY Medical College
SPI-GCF-202 No dispute reported 06/30/2026 1220636414
Principal investigator 1 ABBVIE INC. $425.25 09/03/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab No dispute reported 06/30/2026 1202507365
Principal investigator 1 ABBVIE INC. $750.00 08/28/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202506365
Principal investigator 1 Spectrum Pharmaceuticals Inc. $93,071.18 07/30/2025 Non-covered Recipient Entity
NY Medical College
SPI-GCF-202 No dispute reported 06/30/2026 1220636410
Principal investigator 1 Janssen Research & Development, LLC $15,000.00 06/25/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Phase II Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation in Children, Adolescents and Young Adults with High Risk T-Cell Acute Ly No dispute reported 06/30/2026 1175308101
Principal investigator 1 ABBVIE INC. $4,860.00 05/21/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202485659
Recipient ABBVIE INC. $13,500.00 04/17/2025 Covered Recipient Physician Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab No dispute reported 06/30/2026 1202397477
Principal investigator 1 ABBVIE INC. $750.00 04/16/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202476965
Principal investigator 1 ABBVIE INC. $3,100.00 04/16/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-4) No dispute reported 06/30/2026 1202477060
Principal investigator 1 Adaptive Biotechnologies Corporation $4,050.00 04/11/2025 Non-covered Recipient Entity
New York Medical College
ALLO-T-DART No dispute reported 06/30/2026 1254908923
Principal investigator 1 Spectrum Pharmaceuticals Inc. $164,450.00 04/08/2025 Non-covered Recipient Entity
NY Medical College
SPI-GCF-202 No dispute reported 06/30/2026 1220636439
Principal investigator 1 ABBVIE INC. $750.00 03/27/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
M20-429 - Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab No dispute reported 06/30/2026 1202466746
Principal investigator 1 ABBVIE INC. $1,000.00 03/27/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
M20-429 - Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab No dispute reported 06/30/2026 1202466750
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $17,551.50 02/13/2025 Non-covered Recipient Entity
New York Medical College
A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Participants with Recurrent or Refractory Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma No dispute reported 06/30/2026 1235995359
Principal investigator 1 ABBVIE INC. $1,012.50 01/30/2025 Non-covered Recipient Entity
NEW YORK MEDICAL COLLEGE
M20-429 - Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab No dispute reported 06/30/2026 1202443245
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $207.18 01/27/2025 Non-covered Recipient Entity
New York Medical College
A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Participants with Recurrent or Refractory Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma No dispute reported 06/30/2026 1235995361